Frost.com - Healthcare Research http://www.frost.com/c/10024/home.do http://www.frost.com/c/10024/home.do - Healthcare Research Frost & Sullivan Innovations in Biologic Therapeutics http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-3E-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-3E-00-00 This Genetic Technology TOE depicts trends across biologic therapeutics. With every therapy that is being discovered, there are subsequent discoveries made on the ideal candidates for these therapies. Unfortunately, due to the genetic and cellular variability present in diseases such as cancer, certain therapies are more suitable for a specific strata of patients. The emergence of cell-based therapies and gene therapies will slowly revolutionize personalized therapeutics across diseases that are difficult to treat. The corresponding patent scenario is depicted, along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Biologic therapeutics, chimeric antigen receptor T cell therapy, haematological malignancies, molecular switches, CAR-based T cell therapies, computational immunology, vaccine development, next generation biologic therapeutics, stem cells Fri, 17 Mar 2017 00:00:00 +0000 For Whom the Bill Tolls: The American Healthcare Act and its Implications http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297414305 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297414305 The new healthcare bill unveiled by the Republicans has drawn sharp criticism from citizens, healthcare professionals, and policy makers on both sides of the aisle. Democrats see it as a large tax cut for the rich in the guise of a healthcare act while conservative Republicans feel that the new bill does not do enough to repeal Obamacare. Thu, 16 Mar 2017 00:00:00 +0000 Technologies for Cancer Research http://www.frost.com/prod/servlet/sublib/display-report.do?id=D951-00-0F-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D951-00-0F-00-00 Cancer therapeutics are rapidly evolving with better targets and biologics. The greatest therapeutic current need is present across the indication of cancer. With each individual having a different and more unpredictable form of the disease, the need for personalized medicine is far greater. Hence, novel drug discovery technologies and drug delivery mechanisms are continuously being researched. The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Cancer therapy, biologics, mAbs, antibodies, cancer treatment Fri, 10 Mar 2017 00:00:00 +0000 Advances in Prebiotic and Probiotic Therapies for Disorders of the Gastrointestinal Tract http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-3D-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-3D-00-00 This Genetic Technology TOE depicts trends across prebiotic and probiotic therapies for disorders of the gastrointestinal tract. The corresponding analysis of leading prebiotic and probiotic companies, and the analysis of Top 20 companies with OTC prebiotics and probiotics are depicted along with industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Prebiotic therapies, probiotic therapies, gastrointestinal tract, lactose intolerance, inflammatory bowel disease, diarrhea management, yeasts, intestinal health Fri, 10 Mar 2017 00:00:00 +0000 Innovations in Prebiotic Sugar Substitutes http://www.frost.com/prod/servlet/sublib/display-report.do?id=D768-00-48-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D768-00-48-00-00 This Industrial Bioprocessing TOE features trends and innovations in healthcare sector. The TOE edition focusses on various technology innovations based on prebiotic sugar substitutes and provides insights on the funding scenario. Corresponding patents are also provided along with industry interactions. This Industrial Bioprocessing TOE features trends and innovations in biological solutions for treatment of plastic waste. Biological solutions are being explored by stakeholders to overcome the issues posed by thermochemical processes. The TOE focusses on various technology innovations in biological solutions for treatment of plastic waste and provides insights on technology adoption and funding scenario globally. Corresponding patents are also provided along with industry interactions. The Industrial Bioprocessing TechVision Opportunity Engine (TOE) provides intelligence on technologies, processes and strategic insights of industries involving bioprocessing, including innovations in the development and production of chemicals, pharmaceuticals, nutraceuticals, alternative fuels, chemical feedstocks, food and beverages, and consumer products. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Prebiotic sugar substitutes, insulin, inulin, oligosaccharide sugar substitutes, maltosyl-iso-malto-oligosaccharide, isomaltooligosaccharide, blood glucose management Fri, 10 Mar 2017 00:00:00 +0000 India s Excellent Standing in Biotechnology Drives Rapid Growth Opportunities http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297389298 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297389298 The pharmaceuticals industry is one of the most rapidly growing sectors of the Indian biotechnology sector. Wed, 8 Mar 2017 00:00:00 +0000 3D Printing to Improve Quality of Life for Differentially Abled in Africa http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297381777 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297381777 3D printing is a breakthrough technology that is set to revolutionize the global healthcare industry. One important application is the economic production of customised scaffolds or prosthetics (orthopaedic implants) to assist physically disabled people by substituting for lost or damaged bone. Mon, 6 Mar 2017 00:00:00 +0000 The Role of Data and Analytics in Improving Healthcare Management in South Africa http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297381980 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297381980 Globally, the stakeholders of the healthcare industry are aware of two important priorities. First, the time taken for medical research to result in meaningful changes in clinical practice must reduce. Mon, 6 Mar 2017 00:00:00 +0000 Analysis of the United States Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K0A6-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K0A6-01-00-00-00 Molecular imaging can easily be described as the next frontier of medical imaging. In an era of value-based reimbursement, molecular imaging is set to play a significant role in quicker diagnosis, more accurate disease staging, and selection of targeted treatments. Launch of new radiopharmaceuticals across clinical areas other than cardiology and oncology such as neurology and orthopedics is also expected to drive greater adoption of molecular imaging as part of clinical care pathways. However, molecular imaging continues to face several challenges, notably the high cost of molecular imaging modalities and image scans, competition from lower cost modalities such as CT and MRI, and concerns over future supply of Tc-99m, a key SPECT radiopharmaceutical used for cardiac scans. This study analyzes existing trends in the hybrid molecular imaging and diagnostic radiopharmaceuticals markets with an emphasis on understanding strategies employed by market participants to address these myriad challenges. It also assesses both these markets in the context of changing regulatory and reimbursement policies in order to provide future market trends. This analysis will be critical in helping market participants create long-term viable strategies in order to remain competitive and ensure continuous innovation. This deliverable assesses future trends in molecular imaging equipment revenues as well as growth in the number of unit shipments over the next few years. This will provide value to market participants that design and manufacture molecular imaging equipment. Market participants will also be provided insights on recent industry and technology trends that are shaping the molecular imaging market. Radiopharmaceutical manufacturers will be provided with key insights on the evolving usage trends of workhorse FDG and Tc-99m radiopharmaceuticals and the increasing adoption of new radiopharmaceuticals across new clinical areas. Companies that are in the process of developing software to improve quantitation accuracy, lower dosages, and reduce scan times for both PET and SPECT will be provided with key insights on how the molecular imaging market is growing as well as the factors that are required to facilitate greater adoption of PET and SPECT technologies. Mon, 6 Mar 2017 00:00:00 +0000 Technology Innovations in the Medical Device Industry http://www.frost.com/prod/servlet/sublib/display-report.do?id=D852-00-0F-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D852-00-0F-00-00 The latest issue of the Medical Devices TOE profiles eight innovations spanning the breadth of the MedTech space. These include innovations in the biosensors space, which enable non-invasive and non-contact vital signs monitoring, advanced wound care technologies, minimally-invasive surgical technologies, and innovative cell therapies for bone healing. The Medical Device TechVision Opportunity Engine (TOE) analyzes and reports on new and emerging technologies and advances in R&D; product development; and regulatory matters related to neurology, ophthalmology, respiratory/anesthesia, wound care and management, surgical tools and instrumentation, drug delivery, orthopedics, endoscopy, cardiology, and monitoring. Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Keywords: Biosensors, ingestible sensors, vital signs monitoring, smart medical devices, bone healing Fri, 3 Mar 2017 00:00:00 +0000 Innovations in Disease Detection and Genetic Testing http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-3C-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-3C-00-00 This Genetic Technology TOE depicts trends across disease detection and genetic testing. Genetic testing has been recommended by the American Society of Clinical Oncology (ASCO) for individuals with suspected cancer risk. The next generation gene sequencing panels help identify other family members at the risk of developing the disease. This study profiles key innovations in the field. The corresponding clinical trial assessment is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Disease detection kit, genetic testing, next-generation gene sequencing, integrated genetic testing, personalized medicine, pan-cardio genes Fri, 3 Mar 2017 00:00:00 +0000 Biomarkers Enabling Diabetes and Obesity Management http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7A6-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7A6-01-00-00-00 Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape. Biomarker research is likely to facilitate the emergence of novel tools that may be useful for enhanced management of obesity, diabetes and related complications in the near future. There are several biomarkers that are currently being studied for predicting the risk and progression of several diseases such as type 2 diabetes, diabetic kidney disease, obesity and related disorders. Furthermore, companies are looking to leverage new biomarker-based platforms for early diagnosis and timely clinical management of obesity, diabetes and related complications. Biomarker-based research may also open novel paradigms for drug discovery and development obesity and diabetes disorders. Thu, 2 Mar 2017 00:00:00 +0000 5 Strategic Levers for Digital Health in Asia-Pacific http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297369748 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297369748 Rising healthcare expenditure, ageing population, increasing incidence of chronic and infectious diseases and inefficient supply and management of hospital services are driving governments and providers in the Asia-Pacific (APAC) healthcare industry to explore alternative models of healthcare service delivery. Wed, 1 Mar 2017 00:00:00 +0000 2017 Frost & Sullivan Predictions in Digital Health http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297365660 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297365660 Frost & Sullivan provides comprehensive coverage of numerous information technology products, services, vendors, and regulatory developments impacting global healthcare markets Tue, 28 Feb 2017 00:00:00 +0000 US Employer-Sponsored Private Health Insurance Exchange, Forecast to 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K05B-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K05B-01-00-00-00 Private health insurance exchanges can be broadly defined as online gateways to health insurance, designed to provide single or multiple carrier options to consumers, setup by a private entity. The study describes and defines the market for private health insurance exchange solutions targeted towards beneficiaries of employer-sponsored health insurance; covers factors driving the adoption and deployment of these solutions in response to dynamic industry shifts; discusses key challenges impacting the market for the use of private HIX among employers; provides an overall outlook for future business and IT trends impacting the employer-sponsored private HIX market; and forecasts revenue growth and enrollment growth for the total employer-sponsored private HIX market and key market segments (active and retired employees) for the 5-year period (2016-2020). Included are profiles of 15 leading vendors serving the HIX market as well as a discussion of competitive dynamics impacting vendors today and going forward. Tue, 28 Feb 2017 00:00:00 +0000 Innovations in Healthcare, Air Conditioning Technologies http://www.frost.com/prod/servlet/sublib/display-report.do?id=D707-00-3B-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D707-00-3B-00-00 This edition of the Inside R&D TOE depicts innovations in healthcare and air conditioning systems. The TOE emphasizes on developments in the fields of rapid HIV diagnosis, rapid skin cancer diagnosis, faster tuberculosis treatment, and bionic pancreas. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all technology areas. We provide intelligence and insights on innovations spanning a wide variety of industry areas, including automation, electronics, sensors, information and communication technologies, manufacturing, health, wellness, medical devices, pharma, biotechnology, materials, coatings, renewable fuels, automotive, power systems, sustainable energy solutions and innovations that contribute to a cleaner and greener environment. Keywords: Healthcare, HIV, skin cancer, cancer diagnosis, tuberculosis treatment, bionic pancreas, air conditioning systems Fri, 24 Feb 2017 00:00:00 +0000 Connected Health and Diagnostic Imaging http://www.frost.com/prod/servlet/sublib/display-report.do?id=D861-00-11-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D861-00-11-00-00 This edition of the Medical and Diagnostic Imaging TOE profiles innovations in digital solutions for medical imaging. Some of the profiles covered include evidence-based imaging recommendations, remote healthcare assistance, cloud-based image viewing platform for virtual diagnosis, and ePetri dish platform for smartphone-based imaging to name some. Medical and Diagnostic Imaging TechVision Opportunity Engine (TOE)'s mission is to analyze and report new and emerging technologies; advances in R&D, product development and regulatory matters specifically related to the areas of CT, MRI, NM, PET, Ultrasound and X-ray. In addition, relevant developments in fusion technologies, functional imaging technology, interventional cardiology and image guided surgery and healthcare IT related areas such as PACS, medical information storage, and disaster recovery/business continuance will also be covered. The Health and wellness cluster covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies and imaging technologies and platforms. Keywords: Remote assistance, evidence-based imaging, portable ultrasound, cloud-based image viewing, smartphone-based imaging Fri, 24 Feb 2017 00:00:00 +0000 Microbiome Therapeutic and Diagnostic Innovations http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-3B-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-3B-00-00 This Genetic Technology TOE depicts trends across microbiome therapeutic and diagnostic innovations. The corresponding diagnostic segment scenario is depicted, along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Ecobiotic drug, clostridium difficile infection, microbiome tools, disease mechanisms, bacterial profiling test, human microbiota Fri, 24 Feb 2017 00:00:00 +0000 Transformation of Medical Device Industry http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297371084 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297371084 The pressure to reduce healthcare expenditure, intensifying competition, and consolidation of hospitals and health systems has brought unprecedented changes in the way medical device companies do business. Wed, 22 Feb 2017 00:00:00 +0000 Future of Asset Tracking in Manufacturing http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7A1-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7A1-01-00-00-00 With the advent of Industry 4.0 and smart factories, it has become a necessity for industries to adopt advanced technologies to improve their manufacturing processes. Asset tracking and monitoring technology is currently adopted by industries for tracking and monitoring asset location and status. Sophisticated monitoring technology can also be categorized under plant asset management systems in which industries leverage such advanced technologies to prevent asset failure and to greatly improve asset performance. This transformational technology is playing a vital role in many key industries or applications such as logistics, warehousing, healthcare, automotive, fleet management, military, and industrial automation. The value and functionality of asset tracking technologies has increased owing to its ability to leverage the Industrial Internet of Things (IIoT) which is set to disrupt traditional manufacturing technologies. This technology and innovation research service entitled Future of Asset Tracking in Manufacturing reviews the recent innovations in asset tracking and evaluates its impact on various industries. Key questions covered in this report: What is the significance and impact of asset tracking technologies across different industries? What is the key industry trends propelling adoption? What are the factors influencing adoption - major drivers and challenges? What are the key innovations? Who are key stakeholders driving R&D initiatives? What are the key partnership activities? What are the future prospects and growth opportunities? How can organizations capitalize opportunities? Tue, 21 Feb 2017 00:00:00 +0000 Medical Device Innovations in Bionics http://www.frost.com/prod/servlet/sublib/display-report.do?id=D852-00-0E-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D852-00-0E-00-00 Bionics refers to cutting-edge electromechanical systems that are used to mimic biological systems, in order to support, augment or elevate their functional output. The latest issue of the Medical Device TOE profiles innovations in bionic systems and their application in orthopedics, cognitive function, vision improvement, and in the restoration of sensory function to limbs. The Medical Device TechVision Opportunity Engine (TOE) analyzes and reports on new and emerging technologies and advances in R&D; product development; and regulatory matters related to neurology, ophthalmology, respiratory/anesthesia, wound care and management, surgical tools and instrumentation, drug delivery, orthopedics, endoscopy, cardiology, and monitoring. Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Keywords: Bionics, neuroprosthetics, robotic exoskeleton, human enablement, brain-computer interface Fri, 17 Feb 2017 00:00:00 +0000 Advances in Gene Therapy for the Management of Neurodegenerative Diseases http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-3A-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-3A-00-00 This Genetic Technology TOE depicts recent advances in gene therapy for the management of neurodegenerative diseases. Genetic technology advances are likely to open novel avenues across gene therapy for management of neurodegenerative diseases. This study focusses on some important innovations in the field. The corresponding clinical trial scenario is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Cholesterol metabolism, Huntington s disease, Alzheimer s Disease, Parkinson s disease, gene therapy, cholesterol metabolism, retromers, neurodegenerative diseases, aromatic l-amino acid decarboxylase targets, telomerase gene therapy Fri, 17 Feb 2017 00:00:00 +0000 Global Healthcare Industry Outlook, 2017 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K152-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K152-01-00-00-00 In this research deliverable, Frost & Sullivan s senior analyst team provides bold perspectives and predictions for the global healthcare industry in 2017. The markets covered include pharmaceuticals and biotech, in-vitro diagnostics, medical devices, medical imaging, and healthcare IT. The analysis captures the impact of trends that are expected to transpire over the upcoming year as organizations shift to prepare for the future. This study provides guidance on where to find the greatest opportunities for expansion. Despite global political uncertainties and a sluggish economic outlook, 2017 will be an amped-up year for the global healthcare industry that promises partial realization of major health policies and initiatives. Future drugs and medical devices will be more targeted to meet the unique needs of emerging markets (e.g., China, India, Brazil) which demonstrate high growth opportunities compared against saturated developed markets in the Western hemisphere. For instance, in the United States and Western Europe, 2017 will be a tipping point for mainstream adoption of popular digital health solutions such as wearables and telehealth as well as a transition phase of noble technologies from research to actionable clinical applications (e.g., diagnostic tools, artificial intelligence, blockchain). The outlook foresees increased collaboration and M&A activities between the life sciences and medical device industries, in which product designs will support prevention of the onset of chronic and degenerative diseases. Key Predictions for 2017 Total Healthcare Industry Include: Action Taken on Prescription Drug Price Inflation A strong push will occur towards price control and transparency measures around drugs. Phase 2 of Value-based Care Deployment - Countries spending >10% of their GDP on healthcare will have more impetus for value-based care. Tech Companies Get Serious About Healthcare - 2017 will mark a tangible shift for tech companies such as Apple, Google, and IBM towards more clinical-oriented solutions. Healthcare Investment to have a Record Year - Confluence of events is poised to make 2017 a banner year for VC investment in healthcare. Digital Transformation Modernizes Behavioral Health Treatment - Behavioral therapies will emerge as efficient alternatives in post-care settings and rehabilitation centers. Novel Point-of-care-testing (POCT) Tools Push Telehealth beyond Video Conferencing The global POCT market is poised to reach over $10.5 billion during 2017. Consumer the New King in Healthcare Decision Making Consumers become top influencers in healthcare decision making. Blockchain Technologies into the Healthcare World - Blockchain will become one of the most important technologies in the healthcare space. Key Questions This Study Will Answer: What are the top healthcare market predictions for 2017? What will the market revenue and growth rate look like for the global healthcare industry? What are the key projections and trends for major healthcare market segments? What are the major macro and micro regional/country-level trends specific to the healthcare industry? What are the key technologies and trends to watch for during 2017? Thu, 16 Feb 2017 00:00:00 +0000 Recent Advances in Cancer Genetics http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-39-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-39-00-00 This Genetic Technology TOE depicts trends across cancer genetics. Constituting a genetic disorder in which the normal control of cell growth is significantly altered, cancer disease represents one of the most globally concerned fields of research. Cancer treatment and diagnostics may find a new hope in cancer genetics, which explains the rapid expansion of this discipline across medical specialties. The corresponding clinical trial analysis is depicted along with industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Genomic companion diagnostic platform, companion diagnostics, prostate cancer, checkpoint inhibitor therapy, human fibroblasts, neural stem cell-based therapy, epigenetics, Ewing sarcoma Fri, 10 Feb 2017 00:00:00 +0000 Non-opioids Solutions for Cancer Treatment and Pain Management http://www.frost.com/prod/servlet/sublib/display-report.do?id=D951-00-0E-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D951-00-0E-00-00 Marine-derived pharmaceuticals have been used as sources of providing a range of chemical diversity in drug discovery. Marine-derived pharmaceuticals are the outcome of a breakthrough application of biotechnology. They enable producing therapeutic agents that could ultimately be used by the medical community to combat life-threatening illnesses. The sudden increase in the utilization of marine-derived pharmaceutical products can be directly linked to the uptake of research activities in this space. These marine derived pharmaceutical products require a significant amount of basic and applied research, so that they can be compared in terms of efficacy and safety and quality to patented pharmaceutical products that are in the market. The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Marine-derived pharmaceuticals, chemical diversity, marine biotechnology, pharmaceutical potential, marine organism Fri, 10 Feb 2017 00:00:00 +0000 Developments in Neuromodulation Therapies http://www.frost.com/prod/servlet/sublib/display-report.do?id=D835-00-17-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D835-00-17-00-00 This edition of FT TOE covers technological developments and commercial implications of various neuromodulation therapies that are redefining the standard of care offered by traditional drug-based therapies. The issue covers a snapshot of the global neuromodulation industry, highlighting the intensity of research and commercial prospects for newer clinical applications of these therapies. Detailed analysis of the market and technological drivers and challenges are covered, along with their influence on value of care offered to patients. The issue covers four innovation portfolios within this technology sector, including information and analyst insights on potential business models that could redefine healthcare. The Future Tech TechVision Opportunity Engine (TOE) captures emerging innovations in research and development, or profile existing technologies which have seen a resurgence in terms of new markets and applications. It usually provides a technology overview, drivers, challenges, research and development, analyst insights and key patent information. In some cases, technology convergence scenarios and future growth opportunities are outlined. It covers innovations and technologies in a variety of industry spaces including manufacturing, sensors, electronics, information and communications technologies, networks, lighting technologies, healthcare, medical devices, materials and coatings, and developments in the energy sector that contribute toward a sustainable and greener world. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Neuromodulation therapies, deep brain stimulation, spinal cord stimulation, depression therapies Fri, 3 Feb 2017 00:00:00 +0000 Mobile Health and Telemedicine Markets in Brazil, Forecast to 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K08F-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K08F-01-00-00-00 Brazil s telemedicine market is likely to increase from $495.3 million in 2015 to $743.8 million in 2017 whereas the mHealth market revenue will grow from $446.8 million to $1.43 billion over the same period. Telemedicine is strongly focused on teleradiology in Brazil, which represents over 98% of the market segment revenue. Other telemedicine applications encompass real-time solutions such as specialist consultation and distance learning/education. mHealth is a promising market with a broad range of applications including delivery through telemedicine. Nevertheless, it encounters several barriers to realizing the market potential. From wearables to apps, vital signs remote monitoring and chronic disease management, mHealth is constantly transforming the entire ecosystem with new value proposition and solutions. Digital health in Brazil offers huge opportunity given that industry convergence is transforming how care is delivered via the intersection between the healthcare and ICT industries. Forecast Segmentation: mHealth focus on chronic patient management, telecom counseling, wearables and connected devices, paid applications Telemedicine focus on tele-imaging and real-time telemedicine Research Scope: Telemedicine and mHealth products and services, including perspectives on current and future trends (findings discussed within the context of Frost & Sullivan s views regarding the telehealth industry in Brazil) Market introduction (definitions of scope, stage of mHealth and telemedicine, regulatory space) Market forecasts and trends for 2016 2020 (areas of growth opportunity near and long term, key drivers and restraints, novel business models) Market value chain (key stakeholders in both mHealth and telemedicine markets) Strategic imperatives (key requirements to succeed in the Brazilian marketplace going forward) Key Questions This Study Will Answer: What is the current stage of mHealth and telemedicine in Brazil? Which areas in mHealth and telemedicine provide growth opportunities in the near and long term? What are the key drivers and restraints impacting the mHealth and telemedicine markets? Who are the key stakeholders in Brazil that are part of the digital health value chain? What are the key requirements to succeed in the Brazilian marketplace going forward? The Brazilian telehealth market includes an array of health IT, tech, and communication technologies stakeholders who are stepping forward to be a part of a complex ecosystem of digital health where health data collection, curation, and effective utilization will be mandatory as the market evolves. While some areas are more limited than what is occurring elsewhere (e.g., North America), sectors such as teleradiology/tele-imaging and specialist services represent realized value opportunities that boost market revenue. It is essential for vendors to understand fully the Brazilian healthcare market and its inherent idiosyncrasies to optimize chances of success, especially if looking to enter from another country or region. This study provides readers an overview of the key market factors, drivers and restraints, and value chain activity specific to Brazil, including vendors throughout the ecosystem, company cases, and a insightful view of country s healthcare landscape. Fri, 3 Feb 2017 00:00:00 +0000 Recent Innovations in Healthcare, Electric Vehicles, Artificial Intelligence, and Food Packaging http://www.frost.com/prod/servlet/sublib/display-report.do?id=D707-00-38-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D707-00-38-00-00 This edition of the Inside R&D TOE depicts trends in a series of developments associated with innovations in healthcare, electric vehicles, artificial intelligence, and the food packaging industry. The TOE focuses on innovations in for skin cancer diagnosis using a software program and it also showcases advances in surgical instruments, which can view delicate blood vessels using infrared light. The TOE also emphasizes on automobile innovations such as development of advanced energy management system (EMS) mechanisms and food packaging innovations such as using biodegradable film packaging. It also provides information related to use of artificial intelligence- and machine learning-based software to spot and prevent child abuse in P2P networks and prevent it. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all technology areas. We provide intelligence and insights on innovations spanning a wide variety of industry areas, including automation, electronics, sensors, information and communication technologies, manufacturing, health, wellness, medical devices, pharma, biotechnology, materials, coatings, renewable fuels, automotive, power systems, sustainable energy solutions and innovations that contribute to a cleaner and greener environment. Keywords: Skin cancer, artificial intelligence, brain biopsies, hybrid electric vehicles, EMS for vehicles, child abuse prevention, food packaging, biodegradable film, nanocomposite films Fri, 3 Feb 2017 00:00:00 +0000 Recent Advances across Genetic Discoveries http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-38-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-38-00-00 With the increase in gene-based technologies such as gene regulation and gene editing, there have been a number of recent discovers across genetic technologies. Currently, there is keen interest toward developing novel treatments based on genes that have been discovered to have a major linkage to the development and progression of certain rare diseases. A prominent rare disease that is being actively researched is the Fragile X Syndrome. There are also a range of companies that have successfully utilized gene editing techniques to develop diseases resistance in mammalian species. Such gene editing techniques could revolutionize the manner in which human diseases can be cured in the near future. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Gene editing technique, gene regulation, genetic technologies, Fragile X Syndrome, rare genetic diseases, hybrid embryos, pig chimera, CRISPR Fri, 3 Feb 2017 00:00:00 +0000 Nanotechnology Aids in Effective Cancer Therapy http://www.frost.com/prod/servlet/sublib/display-report.do?id=D787-00-38-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D787-00-38-00-00 Researchers are leveraging nanotechnology by manipulating molecules and structures much smaller than a single cell to enhance the capability to monitor and destroy cancer cells in human body. New biocompatible materials that are highly sensitive and precise enough to destroy cancer cells without harming healthy cells are becoming a prime area of research focus. Research is also focused toward solutions that have superior targeting capabilities. Traditional cancer drugs are being replaced with technologies either with nanomaterials or nanoencapsulation to disintegrate the carcinogenic entity and/or destroy its nutritional support as a whole. The Nanotech TechVision Opportunity Engine (TOE) provides intelligence on technologies, products, processes, applications, and strategic insights on nanotechnology-related innovations and their impact across various industries. Technology focus areas include nanomaterials, nanocoatings, nanohealthcare, nanomedicine, and nanomanufacturing. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Carcinogenic, radiotherapy, oncology, selectivity Fri, 3 Feb 2017 00:00:00 +0000 Review of Key Medical Imaging and Informatics Market Trends from RSNA 2016 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297277239 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297277239 Frost & Sullivan again attended the annual meeting of the Radiological society of North America (RSNA). Thu, 2 Feb 2017 00:00:00 +0000 Spain s New Business Models in Medical Imaging, Forecast to 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MBFB-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MBFB-01-00-00-00 Low economic growth and limited access to capital funding compel hospitals in Spain to adopt new purchasing and service models for imaging equipment. The drive to operationalize capital and service costs favors non-conventional business models in Spain over traditional capital-intensive purchasing and service models. Vendor-customer engagement over 10 to 15 years includes a broad range of value-adding services not limited to in-time renewal and procurement of new equipment. Equipment vendors and multi-vendor service providers are improving their solutions designed to provide a long-term partner-based service model with a commitment to outcomes and a risk-sharing component. This study presents the addressable market for medical imaging Managed Equipment Services (MES) and Multi-vendor Services (MVS) in Spain. The research service also discusses case studies, market opportunity, the competitive landscape, along with growth opportunities and companies to action. Thu, 2 Feb 2017 00:00:00 +0000 European Next-generation Sequencing Services Market, Forecast to 2023 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MCE8-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MCE8-01-00-00-00 The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: Revenue Forecasts Regional Market Dynamics Market Share Analysis and Top Countries Key Trends and Growth Opportunities Game-changing Companies Disruptive Technologies and Business Models Disruptive technologies in NGS are revolutionising the healthcare industry. Launch of high-throughput sequencers has set new service standards, with focus on superior coverage and accuracy. Low-cost and quick turnaround features have amplified NGS uptake as an alternative to traditional methods such as microarray, capillary electrophoresis, and Sanger, propelling the demand for NGS services across areas such as human genetics, plant and animal biotech, agriculture, food and drug safety, and forensics. The European NGS services market is forecast to grow at a CAGR of 15.4% from 2016 to 2023 to reach $605.0 million by 2023. A relatively slow adopter of the technology, Europe now contributes to roughly a third of the global NGS services market size. Government-backed large-scale projects in the region such as the 100,000 Genomes Project of the United Kingdom (UK) and France Genomic Medicine Plan 2025 are poised to bring NGS to the forefront. Industry stakeholders are adapting to current market needs and aligning services with growth opportunities in research and clinical applications. The research service explores current industry trends and market response to the growing sequencing demand. The NGS services market in Europe has been comprehensively studied to understand the core value proposition of game-changing service providers. Industry-wide collaborations, focusing on diversified applications and value-added services, have also been discussed. The study provides an overview of the regional market dynamics focusing on key disruptive factors affecting market growth. The regional market is further segmented and market attractiveness of top countries has been studied. Market size estimations have been provided for Germany, United Kingdom, France, Spain, Italy, and Rest of Europe. Detailed coverage of NGS services market in Germany, UK, and France has been included. Drivers and restraints have been provided for a comprehensive time-bound assessment of the factors influencing the market paradigm. The study also reveals growth opportunities focusing on market needs across diversified application areas. The base year for the study is 2016, with the forecast period being 2017 to 2023. Key Questions this Study will Answer: How is the market attractiveness for NGS services growing over the years? What is the future market potential? How is the $1000 cost per genome milestone distressing market paradigm? What are the factors driving NGS services demand? What are the disruptions affecting the value chain equilibrium? What will be the focal areas on application-based services? Which are the service lines with maximum growth potential? How are the new technology trends impacting service providers? Which are the game-changing companies at work? What are the strategic levers to stay on the growth trajectory? How is the changing economic scenario affecting the regional market? Which are the key markets in Europe?--BEGIN PROMO--

Recent technological advancements in high-throughput sequencing are shifting the industry paradigm. Continued reduction in price per genome advertently impacting the market by increasing scale of sequencing projects. Launch of high-throughput sequencers setting new service standards with focus on superior coverage and accuracy. Low-cost and quick turnaround features have amplified NGS uptake as an alternative to traditional methods such as microarray, capillary electrophoresis and Sanger, propelling demand across industries- Human Genetics, Plant & Animal Biotech, Agriculture, Microbiome, Food & Drug Safety, Forensics.

KEY QUESTIONS THIS WILL ANSWER?

  • How is the market attractiveness for European NGS Services growing over the years? What is the future market potential?

  • Which are the game changing companies at work? What are the strategic levers to stay on the growth trajectory?

  • How is the changing economic scenario affecting the regional market? Which are the key markets in Europe?

Thu, 2 Feb 2017 00:00:00 +0000
Innovations in Disease Inspection and Diagnosis http://www.frost.com/prod/servlet/sublib/display-report.do?id=D861-00-10-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D861-00-10-00-00 This edition of the Medical and Diagnostic Imaging TOE depicts technology trends in disease inspection and diagnostic imaging markets, covering key IP trends and innovation profiles in the areas of: development of portable ultrasound scanner systems for low-income setting and remote areas, tetrahertz radiation for cancer diagnosis, cardiac mapping systems that is 10 times faster than conventional arrhythmia detection systems, and development of systems that use augmented reality platforms for surgical planning. Insights on future growth prospects for each of the innovation spotlight is also depicted along with the industry interactions. Medical and Diagnostic Imaging TechVision Opportunity Engine (TOE)'s mission is to analyze and report new and emerging technologies; advances in R&D, product development and regulatory matters specifically related to the areas of CT, MRI, NM, PET, Ultrasound and X-ray. In addition, relevant developments in fusion technologies, functional imaging technology, interventional cardiology and image guided surgery and healthcare IT related areas such as PACS, medical information storage, and disaster recovery/business continuance will also be covered. The Health and wellness cluster covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies and imaging technologies and platforms. Keywords: Wireless ultrasound scanning systems, portable ultrasound, tetrahertz radiation, cardiac mapping system, augmented reality, surgical planning, conventional arrhythmia detection systems Fri, 27 Jan 2017 00:00:00 +0000 Recent Advances Enabling Enhanced Management of Neurological Disorders http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-37-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-37-00-00 Neurological disorders constitute a significant portion of current patient problems, which require better targeted therapeutics. At present there are a plethora of different technologies that will enable early detection of a range of neurological disorders. In this issue of Genetic Technology TOE, a comprehensive overview of point of care diagnostics as well as related biomarkers that will escalate the capability of developing novel therapeutics is presented. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Point of care, neurological disorders, Alzheimer's Disease, magnetic resonance imaging, blood biomarkers Fri, 27 Jan 2017 00:00:00 +0000 The Future of the United States http://www.frost.com/prod/servlet/sublib/display-report.do?id=NEE6-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=NEE6-01-00-00-00 Frost & Sullivan's research service on The Future of the United States offers a comprehensive analysis of the Mega Trends that will impact American citizens and businesses through 2025. In this research, Frost & Sullivan's expert analysts highlight the imminent challenges and opportunities for growth stemming from the following trends: Social, Higher education, Politics, Industry, Health, wellness and wellbeing, Urbanization, Infrastructure, Mobility, Energy, Security and defense, Economics, Connectivity, Smart is the new green The study also offers strategic recommendations and predictions backed by relevant facts and statistics.--BEGIN PROMO--

Market Overview

Collaboration will define both personal and professional lives

Over the next 10 years, several social, technological, political and economic forces will reshape the business and lifestyle patterns of society in the United States. As Millennials age into management roles and government positions, they will wield significant influence on the American community. Consequently, organizations will re-prioritize competitive dimensions in order to adapt to changing customer dynamics.

Connectivity will penetrate industries and daily life through the Internet of Things. Cities will invest in smart technologies to forge new avenues for commerce and collaboration. This collaboration will lead to greater asset sharing, enhanced inter-business partnerships and strengthened employer-employee relationships. Subsequently, cybersecurity will emerge as a critical point of focus and technologies will become more proactive, adaptive and collaborative to protect against new risks. In spite of several challenges such as mounting student debts and aging infrastructure, the evolution of smart cities, advances in security technology and new jobs created by automation will revive the American dream.

Thu, 26 Jan 2017 00:00:00 +0000
Digitalization in Healthcare: Emergence of Digital Health Portals http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297252585 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297252585 THE WIDESPREAD ADOPTION OF INFORMATION AND COMMUNICATION TECHNOLOGY (ICT) TOOLS AND APPLICATIONS IS TRANSFORMING ALMOST ALL ASPECTS OF INDUSTRIES, AND THE HEALTHCARE SECTOR IS NO EXCEPTION. Wed, 25 Jan 2017 00:00:00 +0000 CEOs Perspectives on Growth, Innovation, and Leadership in the Americas, 2016 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K186-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K186-01-00-00-00 Economies across the Americas are undergoing intense disruption. Digital transformation, competitive complexities, and changing customer demands are fostering new business models and strategic responses. This offers visionary CEOs the prospect of reshaping the business landscape and accelerating unique growth and innovation opportunities. Frost & Sullivan's annual survey of CEOs Perspectives on Growth, Innovation, and Leadership in the Americas, 2016 offers insights into how business leaders are dealing with this volatility and future-proofing their growth. About 75% of survey respondents cite revenue growth as their top growth objective over the next five years. They are adopting a variety of strategies to drive this agenda, even as they grapple with a volatile economic environment characterized by rapid and widespread technological transformation. The digital transformation of their business ecosystems highlights the need for new alliances and partnerships. While more than 40% of CEOs believe that they will rely on strategic partnerships to drive their organizations growth in the next three years, more than half acknowledge that they lag behind in effectively implementing such strategies. Rapidly changing customer behavior and demand, the growing importance of global connectivity and Big Data/intelligent data analytics, and the increasing relevance of new business models are also themes that have been discussed by CEOs in the survey. What are the ways in which organizations are responding to this environment? What are the complementary strategies they are adopting? Which best practices are fostering growth? Who are the disruptive innovators that are embracing and creating new opportunities? Today, disruptive innovators have transformed almost all industries across the global business landscape. Companies that do not embrace this disruption and fail to focus on innovation and growth, integrate new business models, and align with customer needs will find themselves increasingly marginalized. Key Questions the Study will Answer: What are the key growth objectives for organizations over the next five years? Are companies achieving their growth objectives? If not, what is holding them back? What are the top 10 growth opportunity themes for the future and which ones are organizations most likely to leverage? Which major strategies have driven maximum growth for organizations in the past three years and which strategies are organizations most likely to rely on to drive growth in the next three years? In what direction are stakeholder expectations evolving and what are some of the strategic responses that organizations are adopting to address these demands? What do organizations identify as being their most significant external and internal challenges? How do companies rate their growth and innovation performance? Which top technologies, Mega Trends, and business models have the potential to disrupt organizations? Which companies are identified as the most disruptive industry innovators? Wed, 25 Jan 2017 00:00:00 +0000 CEOs Perspectives on Growth, Innovation, and Leadership in Asia, 2016 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K15B-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K15B-01-00-00-00 Asian economies are in the midst of intense disruption. Digital transformation, competitive complexities, and changing customer demands are fostering new business models and strategic responses. This offers visionary CEOs the prospect of reshaping the business landscape, and accelerating unique growth and innovation opportunities. Frost & Sullivan's annual CEOs Perspectives on Growth, Innovation, and Leadership in Asia, 2016 is an in-depth survey of business leaders from a wide cross-section of industries, with the overarching themes of growth, innovation, and leadership. It offers insights into how Asia's business leaders are tackling this volatility and future-proofing their growth. Revenue growth is the number 1 growth objective for CEOs over the next five years. Organizations, however, cite growth strategy implementation as a critical challenge. The CEO survey reveals the areas in which CEOs and business leaders need to improve their performance to steer a course of growth amidst increasing competitive pressures. Digital transformation is highlighted as a dominant growth, innovation and leadership catalyst over the next five years. However, the CEO survey indicates that the speed of technology change represents a real and immediate challenge, while also revealing the strategies CEOs are employing to drive maximum gains from digital disruption. Growth, competition, technology advances and changing stakeholder demands are germinating new business models. However, respondents indicate difficulties in integrating and strategically executing new business models. The CEO survey details some of the key emerging business models and evaluates whether companies have been able to effectively integrate these new business models into their organizations to drive growth. Disruptive innovators have transformed virtually every industry across the global business landscape. Organizations that do not embrace this disruption, fail to focus on innovation and growth, integrate new business models, and align with customer needs will find themselves increasingly marginalized. Frost & Sullivan's CEO s Perspectives on Growth, Innovation, and Leadership in Asia, 2016 provides vital insights into the ways organizations are strategically responding to this environment. It spotlights emerging technologies, Mega Trends, and business models that are creating unparalleled opportunities for sustained growth, disruptive innovation, and visionary leadership. Key Questions the Study will Answer: What are the key growth objectives for organizations over the next 5 years? Are companies achieving their growth objectives? If not, what is holding them back? What are the top ten growth opportunity themes for the future and which ones are organizations most likely to leverage? Which major strategies have delivered the most growth to organizations in the past three years and which strategies are organizations most likely to rely on to drive growth in the next three years? In what direction are stakeholder expectations evolving and what are some of the strategic responses that organizations are adopting to address these demands? What do organizations identify as being their most significant external and internal challenges? How do companies rate their growth and innovation performance? Which top technology, Mega Trends and business models have the potential to disrupt organizations? Which companies are identified as the most disruptive industry innovators? Tue, 24 Jan 2017 00:00:00 +0000